aluates Reports

$ 0.0

Global Sorafenib API Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-6L12257

Global Sorafenib API Market Research Report 2022

BUY CHAPTERS

Global Sorafenib API Market Research Report 2025

Code: QYRE-Auto-6L12257

Report

February 2025

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Hunan Huateng Pharmaceutical

Anhui Haikang Pharmaceutical

Chongqing Carelife Pharmaceutical

Sichuan Xieli Pharmaceutical

NEWEDGE Overseas

Teva API

Alembic Pharmaceuticals

Biotechnica Pharma Global

Bulat Pharmaceutical

EstechPharma

Jeil pharmaceutical

MSN Laboratories

Vannsh Life Sciences

BDR Pharmaceuticals

Cdymax

Stason Pharmaceuticals

Aurobindo Pharma

KriSan Biotech

Sorafenib API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Sorafenib API Market

The global market for Sorafenib API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sorafenib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib API.

The Sorafenib API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sorafenib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sorafenib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sorafenib API Market Report

Report Metric	Details
Report Name	Sorafenib API Market
CAGR	5%
by Type	0.99 0.995 0.999 Others
by Application	Tablets Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hunan Huateng Pharmaceutical, Anhui HaiKang Pharmaceutical, Chongqing Carelife Pharmaceutical, Sichuan Xieli Pharmaceutical, NEWEDGE Overseas, KriSan Biotech, Teva API, Alembic Pharmaceuticals, Aurobindo Pharma, BDR Pharmaceuticals, Biotechnica Pharma Global, Bulat Pharmaceutical, Cdymax, Estechpharma, Jeil Pharmaceutical, MSN Laboratories, Stason Pharmaceuticals, Vannsh Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sorafenib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Sorafenib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Sorafenib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sorafenib API Market report?

Ans: The main players in the Sorafenib API Market are Hunan Huateng Pharmaceutical, Anhui HaiKang Pharmaceutical, Chongqing Carelife Pharmaceutical, Sichuan Xieli Pharmaceutical, NEWEDGE Overseas, KriSan Biotech, Teva API, Alembic Pharmaceuticals, Aurobindo Pharma, BDR Pharmaceuticals, Biotechnica Pharma Global, Bulat Pharmaceutical, Cdymax, Estechpharma, Jeil Pharmaceutical, MSN Laboratories, Stason Pharmaceuticals, Vannsh Life Sciences

What are the Application segmentation covered in the Sorafenib API Market report?

Ans: The Applications covered in the Sorafenib API Market report are Tablets, Others

What are the Type segmentation covered in the Sorafenib API Market report?

Ans: The Types covered in the Sorafenib API Market report are 0.99, 0.995, 0.999, Others

1 Sorafenib API Market Overview

1.1 Product Definition

1.2 Sorafenib API by Type

1.2.1 Global Sorafenib API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 0.99

1.2.3 0.995

1.2.4 0.999

1.2.5 Others

1.3 Sorafenib API by Application

1.3.1 Global Sorafenib API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Tablets

1.3.3 Others

1.4 Global Market Growth Prospects

1.4.1 Global Sorafenib API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Sorafenib API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Sorafenib API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Sorafenib API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Sorafenib API Production Market Share by Manufacturers (2020-2025)

2.2 Global Sorafenib API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Sorafenib API, Industry Ranking, 2023 VS 2024

2.4 Global Sorafenib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Sorafenib API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Sorafenib API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Sorafenib API, Product Offered and Application

2.8 Global Key Manufacturers of Sorafenib API, Date of Enter into This Industry

2.9 Sorafenib API Market Competitive Situation and Trends

2.9.1 Sorafenib API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Sorafenib API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Sorafenib API Production by Region

3.1 Global Sorafenib API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Sorafenib API Production Value by Region (2020-2031)

3.2.1 Global Sorafenib API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Sorafenib API by Region (2026-2031)

3.3 Global Sorafenib API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Sorafenib API Production Volume by Region (2020-2031)

3.4.1 Global Sorafenib API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Sorafenib API by Region (2026-2031)

3.5 Global Sorafenib API Market Price Analysis by Region (2020-2025)

3.6 Global Sorafenib API Production and Value, Year-over-Year Growth

3.6.1 North America Sorafenib API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Sorafenib API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Sorafenib API Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Sorafenib API Production Value Estimates and Forecasts (2020-2031)

4 Sorafenib API Consumption by Region

4.1 Global Sorafenib API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Sorafenib API Consumption by Region (2020-2031)

4.2.1 Global Sorafenib API Consumption by Region (2020-2025)

4.2.2 Global Sorafenib API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Sorafenib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Sorafenib API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Sorafenib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Sorafenib API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Sorafenib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Sorafenib API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Sorafenib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Sorafenib API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Sorafenib API Production by Type (2020-2031)

5.1.1 Global Sorafenib API Production by Type (2020-2025)

5.1.2 Global Sorafenib API Production by Type (2026-2031)

5.1.3 Global Sorafenib API Production Market Share by Type (2020-2031)

5.2 Global Sorafenib API Production Value by Type (2020-2031)

5.2.1 Global Sorafenib API Production Value by Type (2020-2025)

5.2.2 Global Sorafenib API Production Value by Type (2026-2031)

5.2.3 Global Sorafenib API Production Value Market Share by Type (2020-2031)

5.3 Global Sorafenib API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Sorafenib API Production by Application (2020-2031)

6.1.1 Global Sorafenib API Production by Application (2020-2025)

6.1.2 Global Sorafenib API Production by Application (2026-2031)

6.1.3 Global Sorafenib API Production Market Share by Application (2020-2031)

6.2 Global Sorafenib API Production Value by Application (2020-2031)

6.2.1 Global Sorafenib API Production Value by Application (2020-2025)

6.2.2 Global Sorafenib API Production Value by Application (2026-2031)

6.2.3 Global Sorafenib API Production Value Market Share by Application (2020-2031)

6.3 Global Sorafenib API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Hunan Huateng Pharmaceutical

7.1.1 Hunan Huateng Pharmaceutical Sorafenib API Company Information

7.1.2 Hunan Huateng Pharmaceutical Sorafenib API Product Portfolio

7.1.3 Hunan Huateng Pharmaceutical Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Hunan Huateng Pharmaceutical Main Business and Markets Served

7.1.5 Hunan Huateng Pharmaceutical Recent Developments/Updates

7.2 Anhui HaiKang Pharmaceutical

7.2.1 Anhui HaiKang Pharmaceutical Sorafenib API Company Information

7.2.2 Anhui HaiKang Pharmaceutical Sorafenib API Product Portfolio

7.2.3 Anhui HaiKang Pharmaceutical Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Anhui HaiKang Pharmaceutical Main Business and Markets Served

7.2.5 Anhui HaiKang Pharmaceutical Recent Developments/Updates

7.3 Chongqing Carelife Pharmaceutical

7.3.1 Chongqing Carelife Pharmaceutical Sorafenib API Company Information

7.3.2 Chongqing Carelife Pharmaceutical Sorafenib API Product Portfolio

7.3.3 Chongqing Carelife Pharmaceutical Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Chongqing Carelife Pharmaceutical Main Business and Markets Served

7.3.5 Chongqing Carelife Pharmaceutical Recent Developments/Updates

7.4 Sichuan Xieli Pharmaceutical

7.4.1 Sichuan Xieli Pharmaceutical Sorafenib API Company Information

7.4.2 Sichuan Xieli Pharmaceutical Sorafenib API Product Portfolio

7.4.3 Sichuan Xieli Pharmaceutical Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Sichuan Xieli Pharmaceutical Main Business and Markets Served

7.4.5 Sichuan Xieli Pharmaceutical Recent Developments/Updates

7.5 NEWEDGE Overseas

7.5.1 NEWEDGE Overseas Sorafenib API Company Information

7.5.2 NEWEDGE Overseas Sorafenib API Product Portfolio

7.5.3 NEWEDGE Overseas Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 NEWEDGE Overseas Main Business and Markets Served

7.5.5 NEWEDGE Overseas Recent Developments/Updates

7.6 KriSan Biotech

7.6.1 KriSan Biotech Sorafenib API Company Information

7.6.2 KriSan Biotech Sorafenib API Product Portfolio

7.6.3 KriSan Biotech Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 KriSan Biotech Main Business and Markets Served

7.6.5 KriSan Biotech Recent Developments/Updates

7.7 Teva API

7.7.1 Teva API Sorafenib API Company Information

7.7.2 Teva API Sorafenib API Product Portfolio

7.7.3 Teva API Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Teva API Main Business and Markets Served

7.7.5 Teva API Recent Developments/Updates

7.8 Alembic Pharmaceuticals

7.8.1 Alembic Pharmaceuticals Sorafenib API Company Information

7.8.2 Alembic Pharmaceuticals Sorafenib API Product Portfolio

7.8.3 Alembic Pharmaceuticals Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Alembic Pharmaceuticals Main Business and Markets Served

7.8.5 Alembic Pharmaceuticals Recent Developments/Updates

7.9 Aurobindo Pharma

7.9.1 Aurobindo Pharma Sorafenib API Company Information

7.9.2 Aurobindo Pharma Sorafenib API Product Portfolio

7.9.3 Aurobindo Pharma Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Aurobindo Pharma Main Business and Markets Served

7.9.5 Aurobindo Pharma Recent Developments/Updates

7.10 BDR Pharmaceuticals

7.10.1 BDR Pharmaceuticals Sorafenib API Company Information

7.10.2 BDR Pharmaceuticals Sorafenib API Product Portfolio

7.10.3 BDR Pharmaceuticals Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 BDR Pharmaceuticals Main Business and Markets Served

7.10.5 BDR Pharmaceuticals Recent Developments/Updates

7.11 Biotechnica Pharma Global

7.11.1 Biotechnica Pharma Global Sorafenib API Company Information

7.11.2 Biotechnica Pharma Global Sorafenib API Product Portfolio

7.11.3 Biotechnica Pharma Global Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Biotechnica Pharma Global Main Business and Markets Served

7.11.5 Biotechnica Pharma Global Recent Developments/Updates

7.12 Bulat Pharmaceutical

7.12.1 Bulat Pharmaceutical Sorafenib API Company Information

7.12.2 Bulat Pharmaceutical Sorafenib API Product Portfolio

7.12.3 Bulat Pharmaceutical Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Bulat Pharmaceutical Main Business and Markets Served

7.12.5 Bulat Pharmaceutical Recent Developments/Updates

7.13 Cdymax

7.13.1 Cdymax Sorafenib API Company Information

7.13.2 Cdymax Sorafenib API Product Portfolio

7.13.3 Cdymax Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.13.4 Cdymax Main Business and Markets Served

7.13.5 Cdymax Recent Developments/Updates

7.14 Estechpharma

7.14.1 Estechpharma Sorafenib API Company Information

7.14.2 Estechpharma Sorafenib API Product Portfolio

7.14.3 Estechpharma Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Estechpharma Main Business and Markets Served

7.14.5 Estechpharma Recent Developments/Updates

7.15 Jeil Pharmaceutical

7.15.1 Jeil Pharmaceutical Sorafenib API Company Information

7.15.2 Jeil Pharmaceutical Sorafenib API Product Portfolio

7.15.3 Jeil Pharmaceutical Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Jeil Pharmaceutical Main Business and Markets Served

7.15.5 Jeil Pharmaceutical Recent Developments/Updates

7.16 MSN Laboratories

7.16.1 MSN Laboratories Sorafenib API Company Information

7.16.2 MSN Laboratories Sorafenib API Product Portfolio

7.16.3 MSN Laboratories Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.16.4 MSN Laboratories Main Business and Markets Served

7.16.5 MSN Laboratories Recent Developments/Updates

7.17 Stason Pharmaceuticals

7.17.1 Stason Pharmaceuticals Sorafenib API Company Information

7.17.2 Stason Pharmaceuticals Sorafenib API Product Portfolio

7.17.3 Stason Pharmaceuticals Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.17.4 Stason Pharmaceuticals Main Business and Markets Served

7.17.5 Stason Pharmaceuticals Recent Developments/Updates

7.18 Vannsh Life Sciences

7.18.1 Vannsh Life Sciences Sorafenib API Company Information

7.18.2 Vannsh Life Sciences Sorafenib API Product Portfolio

7.18.3 Vannsh Life Sciences Sorafenib API Production, Value, Price and Gross Margin (2020-2025)

7.18.4 Vannsh Life Sciences Main Business and Markets Served

7.18.5 Vannsh Life Sciences Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Sorafenib API Industry Chain Analysis

8.2 Sorafenib API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Sorafenib API Production Mode & Process Analysis

8.4 Sorafenib API Sales and Marketing

8.4.1 Sorafenib API Sales Channels

8.4.2 Sorafenib API Distributors

8.5 Sorafenib API Customer Analysis

9 Sorafenib API Market Dynamics

9.1 Sorafenib API Industry Trends

9.2 Sorafenib API Market Drivers

9.3 Sorafenib API Market Challenges

9.4 Sorafenib API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Hunan Huateng Pharmaceutical

Anhui Haikang Pharmaceutical

Chongqing Carelife Pharmaceutical

Sichuan Xieli Pharmaceutical

NEWEDGE Overseas

Teva API

Alembic Pharmaceuticals

Biotechnica Pharma Global

Bulat Pharmaceutical

EstechPharma

Jeil pharmaceutical

MSN Laboratories

Vannsh Life Sciences

BDR Pharmaceuticals

Cdymax

Stason Pharmaceuticals

Aurobindo Pharma

KriSan Biotech

List of Tables

Table 1. Global Sorafenib API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Sorafenib API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Sorafenib API Production Capacity (Tons) by Manufacturers in 2024

Table 4. Global Sorafenib API Production by Manufacturers (2020-2025) & (Tons)

Table 5. Global Sorafenib API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Sorafenib API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Sorafenib API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Sorafenib API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Sorafenib API as of 2024)

Table 10. Global Market Sorafenib API Average Price by Manufacturers (US$/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of Sorafenib API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Sorafenib API, Product Offered and Application

Table 13. Global Key Manufacturers of Sorafenib API, Date of Enter into This Industry

Table 14. Global Sorafenib API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Sorafenib API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Sorafenib API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Sorafenib API Production Value Market Share by Region (2020-2025)

Table 19. Global Sorafenib API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Sorafenib API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Sorafenib API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 22. Global Sorafenib API Production (Tons) by Region (2020-2025)

Table 23. Global Sorafenib API Production Market Share by Region (2020-2025)

Table 24. Global Sorafenib API Production (Tons) Forecast by Region (2026-2031)

Table 25. Global Sorafenib API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Sorafenib API Market Average Price (US$/Kg) by Region (2020-2025)

Table 27. Global Sorafenib API Market Average Price (US$/Kg) by Region (2026-2031)

Table 28. Global Sorafenib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 29. Global Sorafenib API Consumption by Region (2020-2025) & (Tons)

Table 30. Global Sorafenib API Consumption Market Share by Region (2020-2025)

Table 31. Global Sorafenib API Forecasted Consumption by Region (2026-2031) & (Tons)

Table 32. Global Sorafenib API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Sorafenib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 34. North America Sorafenib API Consumption by Country (2020-2025) & (Tons)

Table 35. North America Sorafenib API Consumption by Country (2026-2031) & (Tons)

Table 36. Europe Sorafenib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 37. Europe Sorafenib API Consumption by Country (2020-2025) & (Tons)

Table 38. Europe Sorafenib API Consumption by Country (2026-2031) & (Tons)

Table 39. Asia Pacific Sorafenib API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 40. Asia Pacific Sorafenib API Consumption by Region (2020-2025) & (Tons)

Table 41. Asia Pacific Sorafenib API Consumption by Region (2026-2031) & (Tons)

Table 42. Latin America, Middle East & Africa Sorafenib API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 43. Latin America, Middle East & Africa Sorafenib API Consumption by Country (2020-2025) & (Tons)

Table 44. Latin America, Middle East & Africa Sorafenib API Consumption by Country (2026-2031) & (Tons)

Table 45. Global Sorafenib API Production (Tons) by Type (2020-2025)

Table 46. Global Sorafenib API Production (Tons) by Type (2026-2031)

Table 47. Global Sorafenib API Production Market Share by Type (2020-2025)

Table 48. Global Sorafenib API Production Market Share by Type (2026-2031)

Table 49. Global Sorafenib API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Sorafenib API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Sorafenib API Production Value Market Share by Type (2020-2025)

Table 52. Global Sorafenib API Production Value Market Share by Type (2026-2031)

Table 53. Global Sorafenib API Price (US$/Kg) by Type (2020-2025)

Table 54. Global Sorafenib API Price (US$/Kg) by Type (2026-2031)

Table 55. Global Sorafenib API Production (Tons) by Application (2020-2025)

Table 56. Global Sorafenib API Production (Tons) by Application (2026-2031)

Table 57. Global Sorafenib API Production Market Share by Application (2020-2025)

Table 58. Global Sorafenib API Production Market Share by Application (2026-2031)

Table 59. Global Sorafenib API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Sorafenib API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Sorafenib API Production Value Market Share by Application (2020-2025)

Table 62. Global Sorafenib API Production Value Market Share by Application (2026-2031)

Table 63. Global Sorafenib API Price (US$/Kg) by Application (2020-2025)

Table 64. Global Sorafenib API Price (US$/Kg) by Application (2026-2031)

Table 65. Hunan Huateng Pharmaceutical Sorafenib API Company Information

Table 66. Hunan Huateng Pharmaceutical Sorafenib API Specification and Application

Table 67. Hunan Huateng Pharmaceutical Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 68. Hunan Huateng Pharmaceutical Main Business and Markets Served

Table 69. Hunan Huateng Pharmaceutical Recent Developments/Updates

Table 70. Anhui HaiKang Pharmaceutical Sorafenib API Company Information

Table 71. Anhui HaiKang Pharmaceutical Sorafenib API Specification and Application

Table 72. Anhui HaiKang Pharmaceutical Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Anhui HaiKang Pharmaceutical Main Business and Markets Served

Table 74. Anhui HaiKang Pharmaceutical Recent Developments/Updates

Table 75. Chongqing Carelife Pharmaceutical Sorafenib API Company Information

Table 76. Chongqing Carelife Pharmaceutical Sorafenib API Specification and Application

Table 77. Chongqing Carelife Pharmaceutical Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Chongqing Carelife Pharmaceutical Main Business and Markets Served

Table 79. Chongqing Carelife Pharmaceutical Recent Developments/Updates

Table 80. Sichuan Xieli Pharmaceutical Sorafenib API Company Information

Table 81. Sichuan Xieli Pharmaceutical Sorafenib API Specification and Application

Table 82. Sichuan Xieli Pharmaceutical Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Sichuan Xieli Pharmaceutical Main Business and Markets Served

Table 84. Sichuan Xieli Pharmaceutical Recent Developments/Updates

Table 85. NEWEDGE Overseas Sorafenib API Company Information

Table 86. NEWEDGE Overseas Sorafenib API Specification and Application

Table 87. NEWEDGE Overseas Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. NEWEDGE Overseas Main Business and Markets Served

Table 89. NEWEDGE Overseas Recent Developments/Updates

Table 90. KriSan Biotech Sorafenib API Company Information

Table 91. KriSan Biotech Sorafenib API Specification and Application

Table 92. KriSan Biotech Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. KriSan Biotech Main Business and Markets Served

Table 94. KriSan Biotech Recent Developments/Updates

Table 95. Teva API Sorafenib API Company Information

Table 96. Teva API Sorafenib API Specification and Application

Table 97. Teva API Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Teva API Main Business and Markets Served

Table 99. Teva API Recent Developments/Updates

Table 100. Alembic Pharmaceuticals Sorafenib API Company Information

Table 101. Alembic Pharmaceuticals Sorafenib API Specification and Application

Table 102. Alembic Pharmaceuticals Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Alembic Pharmaceuticals Main Business and Markets Served

Table 104. Alembic Pharmaceuticals Recent Developments/Updates

Table 105. Aurobindo Pharma Sorafenib API Company Information

Table 106. Aurobindo Pharma Sorafenib API Specification and Application

Table 107. Aurobindo Pharma Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Aurobindo Pharma Main Business and Markets Served

Table 109. Aurobindo Pharma Recent Developments/Updates

Table 110. BDR Pharmaceuticals Sorafenib API Company Information

Table 111. BDR Pharmaceuticals Sorafenib API Specification and Application

Table 112. BDR Pharmaceuticals Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. BDR Pharmaceuticals Main Business and Markets Served

Table 114. BDR Pharmaceuticals Recent Developments/Updates

Table 115. Biotechnica Pharma Global Sorafenib API Company Information

Table 116. Biotechnica Pharma Global Sorafenib API Specification and Application

Table 117. Biotechnica Pharma Global Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Biotechnica Pharma Global Main Business and Markets Served

Table 119. Biotechnica Pharma Global Recent Developments/Updates

Table 120. Bulat Pharmaceutical Sorafenib API Company Information

Table 121. Bulat Pharmaceutical Sorafenib API Specification and Application

Table 122. Bulat Pharmaceutical Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 123. Bulat Pharmaceutical Main Business and Markets Served

Table 124. Bulat Pharmaceutical Recent Developments/Updates

Table 125. Cdymax Sorafenib API Company Information

Table 126. Cdymax Sorafenib API Specification and Application

Table 127. Cdymax Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 128. Cdymax Main Business and Markets Served

Table 129. Cdymax Recent Developments/Updates

Table 130. Estechpharma Sorafenib API Company Information

Table 131. Estechpharma Sorafenib API Specification and Application

Table 132. Estechpharma Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 133. Estechpharma Main Business and Markets Served

Table 134. Estechpharma Recent Developments/Updates

Table 135. Jeil Pharmaceutical Sorafenib API Company Information

Table 136. Jeil Pharmaceutical Sorafenib API Specification and Application

Table 137. Jeil Pharmaceutical Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 138. Jeil Pharmaceutical Main Business and Markets Served

Table 139. Jeil Pharmaceutical Recent Developments/Updates

Table 140. MSN Laboratories Sorafenib API Company Information

Table 141. MSN Laboratories Sorafenib API Specification and Application

Table 142. MSN Laboratories Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 143. MSN Laboratories Main Business and Markets Served

Table 144. MSN Laboratories Recent Developments/Updates

Table 145. Stason Pharmaceuticals Sorafenib API Company Information

Table 146. Stason Pharmaceuticals Sorafenib API Specification and Application

Table 147. Stason Pharmaceuticals Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 148. Stason Pharmaceuticals Main Business and Markets Served

Table 149. Stason Pharmaceuticals Recent Developments/Updates

Table 150. Vannsh Life Sciences Sorafenib API Company Information

Table 151. Vannsh Life Sciences Sorafenib API Specification and Application

Table 152. Vannsh Life Sciences Sorafenib API Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 153. Vannsh Life Sciences Main Business and Markets Served

Table 154. Vannsh Life Sciences Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Sorafenib API Distributors List

Table 158. Sorafenib API Customers List

Table 159. Sorafenib API Market Trends

Table 160. Sorafenib API Market Drivers

Table 161. Sorafenib API Market Challenges

Table 162. Sorafenib API Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sorafenib API

Figure 2. Global Sorafenib API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Sorafenib API Market Share by Type: 2024 VS 2031

Figure 4. 0.99 Product Picture

Figure 5. 0.995 Product Picture

Figure 6. 0.999 Product Picture

Figure 7. Others Product Picture

Figure 8. Global Sorafenib API Market Value by Application, (US$ Million) & (2020-2031)

Figure 9. Global Sorafenib API Market Share by Application: 2024 VS 2031

Figure 10. Tablets

Figure 11. Others

Figure 12. Global Sorafenib API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Sorafenib API Production Value (US$ Million) & (2020-2031)

Figure 14. Global Sorafenib API Production Capacity (Tons) & (2020-2031)

Figure 15. Global Sorafenib API Production (Tons) & (2020-2031)

Figure 16. Global Sorafenib API Average Price (US$/Kg) & (2020-2031)

Figure 17. Sorafenib API Report Years Considered

Figure 18. Sorafenib API Production Share by Manufacturers in 2024

Figure 19. Global Sorafenib API Production Value Share by Manufacturers (2024)

Figure 20. Sorafenib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. The Global 5 and 10 Largest Players: Market Share by Sorafenib API Revenue in 2024

Figure 22. Global Sorafenib API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 23. Global Sorafenib API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 24. Global Sorafenib API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 25. Global Sorafenib API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 26. North America Sorafenib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. Europe Sorafenib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. China Sorafenib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Japan Sorafenib API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global Sorafenib API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 31. Global Sorafenib API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 33. North America Sorafenib API Consumption Market Share by Country (2020-2031)

Figure 34. U.S. Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 35. Canada Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 36. Europe Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 37. Europe Sorafenib API Consumption Market Share by Country (2020-2031)

Figure 38. Germany Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 39. France Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 40. U.K. Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 41. Italy Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 42. Russia Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 43. Asia Pacific Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 44. Asia Pacific Sorafenib API Consumption Market Share by Region (2020-2031)

Figure 45. China Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 46. Japan Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. South Korea Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 48. China Taiwan Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. Southeast Asia Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. India Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Latin America, Middle East & Africa Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 52. Latin America, Middle East & Africa Sorafenib API Consumption Market Share by Country (2020-2031)

Figure 53. Mexico Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. Brazil Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. Turkey Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. GCC Countries Sorafenib API Consumption and Growth Rate (2020-2031) & (Tons)

Figure 57. Global Production Market Share of Sorafenib API by Type (2020-2031)

Figure 58. Global Production Value Market Share of Sorafenib API by Type (2020-2031)

Figure 59. Global Sorafenib API Price (US$/Kg) by Type (2020-2031)

Figure 60. Global Production Market Share of Sorafenib API by Application (2020-2031)

Figure 61. Global Production Value Market Share of Sorafenib API by Application (2020-2031)

Figure 62. Global Sorafenib API Price (US$/Kg) by Application (2020-2031)

Figure 63. Sorafenib API Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions